Cytomx Therapeutics Inc Stock
Price
Target price
€3.57
€3.57
2.610%
0.09
2.610%
-
12.12.25 / Tradegate
WKN: A14158 / Name: CytomX / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Cytomx Therapeutics Inc is only available for our menbers.
Not a member yet? Sign up for free!
Not a member yet? Sign up for free!
Financial data and news for CytomX
sharewise wants to provide you with the best news and tools for CytomX, so we directly link to the best financial data sources.
Financials
News
Why CytomX Therapeutics Stock Was Skyrocketing This Week
It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics
CytomX (CTMX) Q2 Revenue Drops 26%
CytomX Therapeutics (NASDAQ:CTMX), a biotechnology company focused on developing targeted oncology therapies, reported its second quarter 2025 results on August 7, 2025. In the period, the most